Monitor the August 4 earnings release for revenue, profit margins, and segment performance across Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The prior 20-F (annual report) provides a baseline for comparison.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 23 $29.77entry
- T+1 · 4mo ago +2.69%α +2.59% · $30.57
- T+5 · 4mo ago +8.60%α +8.12% · $32.33
- T+20 · 3mo ago −2.45%α −5.76% · $29.04
- T+60 · 5w ago −2.28%α −6.84% · $29.09
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Smith+Nephew filed a 6-K announcing the timing of its Q2 and first-half 2026 results, scheduled for release on August 4, 2026. This is a routine administrative notice with no financial data or material business updates. The filing has no standalone impact on the stock.
Key Facts
- Smith+Nephew will announce Q2 and first-half 2026 results on August 4, 2026.
- Results are for the period ended June 27, 2026.
- A conference call for analysts will follow the release.
- No financial results or guidance are provided in this filing.
Financial Impact
No financial data disclosed in this filing.
Risk Factors
- No material risks disclosed in this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001654954-26-006807 |
| Document: 0001654954-26-006807-index-headers.html | 0001654954-26-006807 |
| Document: 0001654954-26-006807-index.html | 0001654954-26-006807 |
| Document: 0001654954-26-006807.txt | 0001654954-26-006807 |
Track record
42 reports on SNN
6 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +8.02% at T+20 after the Jun 30, 2026 report. 8 of 9 went positive at some point.
Filters
- Nov 12, 20264d ago 6-K Neutral 1/10 Entry $31.00 Now $30.97 −0.10% settles Nov 19
- Nov 4, 202612d ago 6-K Bearish 6/10 No price data
- Nov 4, 202612d ago 6-K Bearish 6/10 Entry $32.46 to $31.04 Now $30.97 +4.59% ▲ +4.37% +3.46% vs SPY
- Nov 2, 202614d ago 6-K Neutral 4/10 Entry $30.24 to $31.05 Now $30.97 +2.41% ▲ +2.68% +2.60% vs SPY
- Oct 22, 202625d ago 6-K Neutral 2/10 Entry $30.88 to $30.22 Now $30.97 +0.29% ▼ −2.14% −2.84% vs SPY
- Oct 8, 20265w ago 6-K Neutral 2/10 Entry $26.96 to $29.09 Now $30.97 +14.87% ▲ +7.90% +8.18% vs SPY
- Oct 1, 20266w ago 6-K Neutral 2/10 Entry $26.58 to $26.96 Now $30.97 +16.52% ▲ +1.43% +0.13% vs SPY
- Oct 1, 20266w ago 6-K Neutral 2/10 Entry $26.58 to $26.96 Now $30.97 +16.52% ▲ +1.43% +0.13% vs SPY
- Sep 23, 20267w ago Press Release Neutral 3/10 Entry $26.82 to $26.96 Now $30.97 +15.47% ▲ +0.52% +1.20% vs SPY
- Sep 23, 20267w ago Press Release Neutral 3/10 Entry $26.82 to $26.96 Now $30.97 +15.47% ▲ +0.52% +1.20% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers